Delving into the Latest Updates on Laboratoire Boreaderme Inc. with Synapse

A Randomized, Open Label, Non-inferiority Study to Compare the Safety and Efficacy of BOR15001L7 to Docosanol 10% in Patients With Recurrent Herpes Labialis

BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis.

开始日期2020-09-01

申办/合作机构

Laboratoire Boreaderme Inc.

NCT02582086 / Unknown statusN/A

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Topical Natural Health Product for the Treatment of Herpes Labialis

The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.

开始日期2016-01-01

申办/合作机构

Laboratoire Boreaderme Inc.

100 项与 Laboratoire Boreaderme Inc. 相关的临床结果

登录后查看更多信息

0 项与 Laboratoire Boreaderme Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Laboratoire Boreaderme Inc. 相关的药物交易

登录后查看更多信息

100 项与 Laboratoire Boreaderme Inc. 相关的转化医学

登录后查看更多信息